Hybrigenics SA
Provider of technologies for studying molecular interactions and antibody selection.
ALHYG | PA
Overview
Corporate Details
- ISIN(s):
- FR0004153930
- LEI:
- 9695003KQD0XMJYDX764
- Country:
- France
- Address:
- 850 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
Description
Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-22 18:00 |
Compte-rendu de l'assemblée générale du 21 décembre 2023
|
French | PDF • 185.9 KB | ||
| 2023-11-17 18:30 |
POINT SUR LA SITUATION DU GROUPE ATON (HYBRIGENICS SA)
|
French | PDF • 255.7 KB | ||
| 2023-10-31 18:00 |
RESULTATS SEMESTRIELS 2023
|
French | PDF • 269.4 KB | ||
| 2023-10-25 18:00 |
ATON (EX-HYBRIGENICS) RENFORCE SES RESSOURCES FINANCIERES EN EMETTANT UN EMPRUN…
|
French | PDF • 297.2 KB | ||
| 2023-10-11 08:00 |
HYBRIGENICS : Stemcis étend ses horizons à l'international avec l'ouverture d'u…
|
French | PDF • 183.5 KB | ||
| 2023-09-26 17:45 |
HYBRIGENICS SE REPOSITIONNE SOUS LE NOM D'ATON ET COMMUNIQUE SA STRATÉGIE POUR …
|
French | PDF • 1.4 MB | ||
| 2023-07-04 18:00 |
Compte-rendu de l'assemblée générale du 28 juin 2023
|
French | PDF • 243.0 KB | ||
| 2023-06-08 18:00 |
Convocation des actionnaires à l'assemblée générale annuelle ordinaire et extra…
|
French | PDF • 194.7 KB | ||
| 2023-04-28 19:00 |
Résultats annuels 2022
|
French | PDF • 251.1 KB | ||
| 2023-04-27 18:30 |
Visioconférence Hybrigenics destinée aux actionnaires et à tous les investisseu…
|
French | PDF • 197.9 KB | ||
| 2023-04-24 10:30 |
Visioconférence destinée aux actionnaires d'Hybrigenics et à tous les investiss…
|
French | PDF • 195.5 KB | ||
| 2023-03-22 08:00 |
Hybrigenics présente les avancées de sa filiale B Cell Design, spécialisée dans…
|
French | PDF • 207.2 KB | ||
| 2023-03-15 08:00 |
Hybrigenics poursuit son plan de développement
|
French | PDF • 189.3 KB | ||
| 2023-03-01 08:30 |
Hybrigenics présente les avancées de sa filiale Inoviem Scientific
|
French | PDF • 222.8 KB | ||
| 2023-02-22 13:15 |
Hybrigenics dévoile les avancées de sa filiale Stemcis
|
French | PDF • 196.3 KB |
Automate Your Workflow. Get a real-time feed of all Hybrigenics SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hybrigenics SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hybrigenics SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
